Compare Mutual Funds
Nippon India Pharma Fund
EquitySectoral-Pharma
Select a Mutual Fund
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.85
-
NAV
₹594.49
-
Fund Started
10 May 2004
-
Fund Size
₹9166.40 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 month.
-
1 Year
2.10%
-
3 Year
14.97%
-
5 Year
11.98%
-
Equity
97.31%
-
Cash
2.67%
-
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.71% |
Divi's Laboratories Ltd. | 7.10% |
Lupin Ltd. | 6.17% |
Cipla Ltd. | 6.01% |
Dr. Reddy's Laboratories Ltd. | 5.45% |
Apollo Hospitals Enterprise Ltd. | 4.89% |
Mankind Pharma Ltd. | 4.38% |
Sai Life Sciences Ltd. | 3.92% |
Ajanta Pharma Ltd. | 3.61% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.11% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
-
Launch Date
10 May 2004
-
